2025-2026 Regular Session

HF2703

Prohibition extended on manufacturers interfering with access to 340B drugs.

Earlier-session bill · introduced 2025

Current disposition: Pending: House Commerce Finance & Policy
Last status date: April 13, 2026
Last status update: Author changed Johnson, P., be shown as Chief Author
Pending committee: Commerce Finance & Policy
Author: Pete Johnson
Co-sponsors: Natalie Zeleznikar Matt Norris Kari Rehrauer

Legislative progress

This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.

Introduced in House March 24, 2025

Open official bill page Latest bill text

Committee referrals

March 24, 2025 · House

Commerce Finance & Policy

Instrument history

This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.

April 13, 2026
House Author stricken Stephenson
April 13, 2026
House Author changed Johnson, P., be shown as Chief Author
April 2, 2025
House Author stricken Backer
April 1, 2025
House Author added Rehrauer
March 26, 2025
House Authors added Johnson, P.; Norris
March 24, 2025
House Introduction and first reading, referred to Commerce Finance and Policy

Source provenance

LegiScan bill ID: 2013557
LegiScan session ID: 2151
Source file: var/states/minnesota/source/legiscan/2151-4c339611e966/bill/HF2703.json
Package observed: 2026-11-07T16:27:48+00:00